DEFRAVO
DEAD

Serial Number

79281022

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jan 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DEFRAVO Trademark

Serial Number: 79281022 • Registration: 6093319

DEFRAVO is a trademark filed by NOVARTIS AG on January 22, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,170 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 22, 2020

Registration Date

July 7, 2020

Published for Opposition

April 21, 2020

Cancellation Date

August 7, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 11, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Aug 11, 2025 DETH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 7, 2025 REM3
NOTIFICATION PROCESSED BY IB
Oct 17, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 19, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 19, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 6, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 7, 2020 R.PR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 6, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 6, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 6, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 6, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 6, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 6, 2020 COAR
PUBLISHED FOR OPPOSITION
Apr 21, 2020 PUBO
NOTICE OF PUBLICATION
Apr 1, 2020 NPUB
APPLICATION FILING RECEIPT MAILED
Mar 21, 2020 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2020 CNSA
ASSIGNED TO EXAMINER
Mar 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 16, 2020 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 12, 2020 SDRC